Prim.dr sci. med. Marijana Milojević- Kovačević, Institut za radiologiju i onkologiju Srbije, članica Stručnog veća Ženskog centra Milica
Sadašnje zvanje: Doktor nauka, primarius
Izbor u sadašnje zvanje: 2010
Broj godina radnog iskustva: 21 godina
Fakultet  DA, godina: 1997
Magisterijum DA  godina:2004

Doktorat DA  godina:2010

Primarijat DA godina: 2014

Visoka/viša/ srednja stručna DA
Reprezentativne reference  u poslednjih deset godina (navesti do 5 referenci):

1. Milovic M, Popov I, Jelic S. Tumor markers in
   metastatic disease from cancer of unknown primary
   origin. Med Sci Monit 2002; 8(2): MTI-6
2. p53 gene mutations and codon 72 polymorphism in
   ovarian carcinoma patients from Serbia (Article) Autori
   Malisic Emina J Jankovic Radmila N Slavkovic D
   Milovic-Kovacevic Marijana Radulovic Sinisa S Info
   JOURNAL OF BUON, (2010), vol. 15 br. 1, str. 101-106
3. Monitoring levels of nephrotoxicity of different aminoglycosides during febrile neutropenia caused by nephrotoxic chemotherapy: a single centre study (Article)Autori Milovic Marijana M Popov Ivan P, Jezdic Svetlana D Stojanovic Suzana Stankovic V Radic S Info JOURNAL OF BUON, (2010), vol. 15 br. 2, str. 297-302
4. . Platinum – sensitive relapsed epithelial ovarian cancer: Not all the patients benefit from reinduction with carboplatin and paclitaxel (Article) Autori Milovic-Kovacevic Marijana Stamatovic Ljiljana Popov Ivan P Radosevic-Jelic Ljiljana M Kezic Iva Info MEDICAL SCIENCE MONITOR, (2010), vol. 16 br. 11, str. CR549-

CR554

5. Popov I, Radosevic-jelic Lj., jezdic S., Milovic M Borojevic N, Stojanovic S, Stankovic V, Josifovski T,Kezic I. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer. J BUON 2008; (13): 505-511

6. Milovic-Kovacevic Marijana M Susnjar Snezana V  Karaferic Andjela et al. Could the lack of expression of steroid receptors and HER2 discriminate a subgroup of triple negative breast cancer patients with poorer prognosis? (Meeting Abstract). BREAST, (2011),

7. Radenkovic Sandra S Milovic-Kovacevic Marijana M  Srdic Tatjana et al. IL-2 Mediated Improvement of Cell Antitumor Activity in Advanced Breast Cancer Patients (Meeting Abstract) BREAST, (2017).

8. Milovic-Kovacevic Marijana M Susnjar Snezana V  Stamatovic Ljiljana . Changing in Tumor Biology of Triple Negative Breast Cancer Between Primary and Metastatic Lesions (Meeting Abstract), BREAST, (2015),

9. Bozovic-Spasojevic Ivana M Susnjar Snezana V  Milovic-Kovacevic Marijana M  et al. INFLUENCE OF HER2 STATUS ON METASTATIC PATTERN IN POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT TAMOXIFEN ONLY (Meeting Abstract) BREAST, (2013),

Trenutno učešće u naučnim projektima:  Projekat Ministarstva za nauku br. 41026

Usavršavanje:

•  II Edukativni kurs” Molekularna onkologija”-Beograd, 17.10.2009.g
• Good Clinical Practice Course, for Investigators, Research Physicians, Site Nurses and other Research Professionals 2 ACRP, Beograd, 23-25.09.2010.
• 13 th Biennial Meeting of the International Gynecologic Cancer Society (IGSC), Oktobar 23-26, Prag, Češka Republika, Evropska Unija
• 12th St. Gallen International Breast Cancer Conference 16-19 March 2011, St.Gallen, Switzerland